Cargando…

In silico veritas? Potential limitations for SARS-CoV-2 vaccine development based on T-cell epitope prediction

Detalles Bibliográficos
Autores principales:	Silva-Arrieta, Sandra, Goulder, Philip J. R., Brander, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272002/ https://www.ncbi.nlm.nih.gov/pubmed/32497149 http://dx.doi.org/10.1371/journal.ppat.1008607

Ejemplares similares

Veritas.
Publicado: (2005)

To Veritas
Publicado: (1808)

The Safety of Anti-SARS-CoV-2 Vaccines: Vigilance Is Still Required
por: Goldman, Michel
Publicado: (2022)

Upper respiratory tract mucosal immunity for SARS-CoV-2 vaccines
por: Fraser, Rupsha, et al.
Publicado: (2023)

In Silico Veritas: The Pitfalls and Challenges of Predicting GPCR-Ligand Interactions
por: Roumen, Luc, et al.
Publicado: (2011)

Harnessing the natural anti-glycan immune response to limit the transmission of enveloped viruses such as SARS-CoV-2
por: Breiman, Adrien, et al.
Publicado: (2020)

SARS-CoV-2 Vaccines: Inactivation by Gamma Irradiation for T and B Cell Immunity
por: Mullbacher, Arno, et al.
Publicado: (2020)

Can live-attenuated SARS-CoV-2 vaccine contribute to stopping the pandemic?
por: Tang, Patrick Chun Hean, et al.
Publicado: (2022)

In Vitro Veritas
por: Vinken, Mathieu
Publicado: (2020)

In Silico and In Vivo Evaluation of SARS-CoV-2 Predicted Epitopes-Based Candidate Vaccine
por: Shehata, Mahmoud M., et al.
Publicado: (2021)

Nano-targeting lessons from the SARS-CoV-2
por: Ribeiro, I.R.S., et al.
Publicado: (2021)

Nonspecific Effects of Infant Vaccines Make Children More Resistant to SARS-CoV-2 Infection
por: Fonte, Luis, et al.
Publicado: (2022)

T Cells: Warriors of SARS-CoV-2 Infection
por: de Candia, Paola, et al.
Publicado: (2021)

The neuroinvasiveness, neurotropism, and neurovirulence of SARS-CoV-2
por: Bauer, Lisa, et al.
Publicado: (2022)

Understanding Laboratory Testing for SARS-CoV-2
por: Cheema, Ritu, et al.
Publicado: (2021)

Novel Nested Peptide Epitopes Recognized by CD4(+) T Cells Induced by HIV-1 Conserved-Region Vaccines
por: Borthwick, Nicola, et al.
Publicado: (2020)

Anti-SARS-CoV-2 Antibodies Testing in Recipients of COVID-19 Vaccination: Why, When, and How?
por: Lippi, Giuseppe, et al.
Publicado: (2021)

In silico T cell epitope identification for SARS-CoV-2: Progress and perspectives
por: Sohail, Muhammad Saqib, et al.
Publicado: (2021)

Anuario de Veritas.
Publicado: (1982)

VERITAS moves ahead
Publicado: (2004)

Rapid deployment of SARS-CoV-2 testing: The CLIAHUB
por: Crawford, Emily D., et al.
Publicado: (2020)

Is Omicron the last SARS-CoV-2 Variant of Concern?
por: Rahimi, Farid, et al.
Publicado: (2022)

Immune Evasion of SARS-CoV-2 Omicron Subvariants
por: Ke, Hanzhong, et al.
Publicado: (2022)

SARS-CoV-2 vaccination in liver transplant recipients: We still haven't found what we are looking for
por: Thompson, Marcos A., et al.
Publicado: (2023)

Veritas : revista trimestral de filosofia da PUCRS.
Publicado: (1955)

Design an Efficient Multi-Epitope Peptide Vaccine Candidate Against SARS-CoV-2: An in silico Analysis
por: Yazdani, Zahra, et al.
Publicado: (2020)

In silico Design and Characterization of Multi-epitopes Vaccine for SARS-CoV2 from Its Spike Protein
por: Kathwate, Gunderao H.
Publicado: (2022)

Potential Applications of Plant Biotechnology against SARS-CoV-2
por: Capell, Teresa, et al.
Publicado: (2020)

SARS-CoV-2–A Tough Opponent for the Immune System
por: Nasab, Mahsa Golshani, et al.
Publicado: (2020)

Virus Eradication and Synthetic Biology: Changes with SARS-CoV-2?
por: Tournier, Jean-Nicolas, et al.
Publicado: (2021)

Are Older People Really More Susceptible to SARS-CoV-2?
por: Zhang, Shuo, et al.
Publicado: (2022)

Heme, Heme Oxygenase-1, Statins, and SARS-CoV-2
por: Stevenson, David K., et al.
Publicado: (2023)

Spying on SARS-CoV-2 with Fluorescent Tags and Protease Reporters
por: To, Tsz-Leung, et al.
Publicado: (2023)

SARS-CoV-2 and the next generations: which impact on reproductive tissues?
por: Zupin, Luisa, et al.
Publicado: (2020)

SARS-CoV-2: Cross-scale Insights from Ecology and Evolution
por: Snedden, Celine E., et al.
Publicado: (2021)

Why Does SARS-CoV-2 Infection Induce Autoantibody Production?
por: Macela, Ales, et al.
Publicado: (2021)

The gut microbiome as a biomarker of differential susceptibility to SARS-CoV-2
por: Sarkar, Amar, et al.
Publicado: (2021)

Compelling Evidence for the Activity of Antiviral Peptides against SARS-CoV-2
por: Tonk, Miray, et al.
Publicado: (2021)

Targeting SARS-CoV-2 papain-like protease in the postvaccine era
por: Ton, Anh-Tien, et al.
Publicado: (2022)

Prediction of SARS-CoV-2-Related Lung Inflammation Spreading by V:ERITAS (Vanvitelli Early Recognition of Inflamed Thoracic Areas Spreading)
por: Romano, Ciro, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qhrelfqlitmep0t8e09lnr6r75